Mode
Text Size
Log in / Sign up

Retrospective study compares antibiotic regimens for H. pylori eradication in children.

Retrospective study compares antibiotic regimens for H. pylori eradication in children.
Photo by CDC / Unsplash
Key Takeaway
Consider cautious interpretation of H. pylori eradication data from this single-center observational study lacking safety details.

This retrospective observational study examined treatment outcomes for children aged 4 to 13 years with confirmed Helicobacter pylori infection. The investigation compared a regimen involving a proton pump inhibitor, amoxicillin, and clarithromycin against an alternative combination containing metronidazole instead of amoxicillin. Both groups received therapy for 10 to 14 days, with eradication status confirmed four weeks after treatment concluded.

The primary focus was on determining the success of these antibiotic strategies in clearing the infection. Secondary observations included patterns of recurrence and other follow-up outcomes extending up to 12 months. The study was conducted within a single pediatric department, which may limit the generalizability of the results to broader populations.

The authors did not report specific adverse events, discontinuations, or tolerability issues within the provided data. Consequently, the safety profile of these specific regimens in this age group remains unclear based on this evidence alone. The observational nature of the study prevents definitive conclusions regarding causality or the superiority of one regimen over the other.

Clinicians should recognize that while eradication was the primary goal, the lack of detailed safety reporting and the single-center setting warrant a conservative approach. These findings may inform discussions but should not replace established guidelines or randomized evidence when making treatment decisions for pediatric patients.

Study Details

Study typeCohort
EvidenceLevel 3
PublishedApr 2026
View Original Abstract ↓
BackgroundHelicobacter pylori infection remains a prevalent chronic bacterial condition in children and is associated with significant long-term gastrointestinal complications, including peptic ulcer disease and an increased risk of gastric malignancy. Although standard triple therapy is widely used as first-line treatment, rising antimicrobial resistance and reinfection continue to challenge eradication success in children. This study aimed to evaluate the comparative effectiveness of two standard triple therapy regimens and to assess follow-up outcomes and recurrence patterns in children diagnosed with H. pylori infection.Materials and methodsThis retrospective observational study was conducted at the Department of Pediatrics, Liuzhou People's Hospital, between January 2023 and December 2025. Children aged 4–13 years with confirmed H. pylori infection were included. Patients received either proton pump inhibitor (PPI) + amoxicillin + clarithromycin (n = 94) or PPI + metronidazole + clarithromycin (n = 34) for 10–14 days. Diagnosis and post-treatment assessment were performed using the ¹³C urea breath test (¹³C UBT), with histopathological confirmation in clinically indicated cases. Eradication was confirmed four weeks after completion of therapy. Follow-up evaluations were conducted at 6 and 12 months to monitor recurrence. Statistical analyses were performed using chi-square and independent t-tests, with p 
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.